ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 22 filers reported holding ANI PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,279,000 | -10.1% | 3,012,000 | 0.0% | 0.00% | – |
| Q2 2019 | $3,649,000 | +27969.2% | 3,012,000 | +25000.0% | 0.00% | – |
| Q1 2019 | $13,000 | +8.3% | 12,000 | 0.0% | 0.00% | – |
| Q4 2018 | $12,000 | -99.9% | 12,000 | -99.9% | 0.00% | -100.0% |
| Q3 2018 | $11,523,000 | -6.1% | 10,882,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $12,272,000 | +3.4% | 10,882,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $11,865,000 | -10.7% | 10,882,000 | -5.9% | 0.00% | -50.0% |
| Q4 2017 | $13,284,000 | +1.4% | 11,570,000 | -4.1% | 0.00% | 0.0% |
| Q3 2017 | $13,096,000 | +3.3% | 12,070,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $12,674,000 | -0.5% | 12,070,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $12,734,000 | -15.1% | 12,070,000 | -7.7% | 0.00% | 0.0% |
| Q4 2016 | $14,998,000 | -9.7% | 13,070,000 | -3.3% | 0.00% | 0.0% |
| Q3 2016 | $16,617,000 | -4.6% | 13,510,000 | -16.6% | 0.00% | 0.0% |
| Q2 2016 | $17,424,000 | +99.2% | 16,190,000 | +65.5% | 0.00% | +100.0% |
| Q1 2016 | $8,747,000 | +17.0% | 9,780,000 | +27.3% | 0.00% | 0.0% |
| Q4 2015 | $7,474,000 | +5.6% | 7,680,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $7,075,000 | +123.4% | 7,680,000 | +156.0% | 0.00% | – |
| Q4 2014 | $3,167,000 | – | 3,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|